Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer, with a high morbidity and low survival rate. Rho GTPase activating protein 39 (ARHGAP39) is a crucial activating protein of Rho GTPases, a novel target in cancer therapy, and it was identified as a hub gene for gastric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yongqi, Gong, Yiyang, Zeng, Hong, Zhou, Xuanrui, Yu, Zichuan, Pan, Jingying, Zhou, Minqin, Liu, Shiwen, Lai, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120899/
https://www.ncbi.nlm.nih.gov/pubmed/37059586
http://dx.doi.org/10.18632/aging.204635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120899/
https://www.ncbi.nlm.nih.gov/pubmed/37059586
http://dx.doi.org/10.18632/aging.204635

Ejemplares similares